
---
title: '普利制药：注射用伏立康唑获得哥斯达黎加卫生部上市许可'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=9833'
author: 证券时报网
comments: false
date: Sun, 31 Oct 2021 16:37:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=9833'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SZ300630" style="color: #2f67d1;text-decoration: none;" code="300630" target="_blank">普利制药</a>(300630)10月31日晚间公告，注射用伏立康唑获得哥斯达黎加卫生部上市许可。</p>

                  
</div>
            